SCHEMBL3344756

SCHEMBL3344756

CCCCCOC[C@H]1O[C@H](OC(C)=O)[C@H](OCCCCC)[C@@H]1OCCCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.43
GJB2 P29033 4/20 0.43
MAPK1 P28482 1/20 0.40
SSTR1 P30872 1/20 0.39
SSTR2 P30874 1/20 0.39
SSTR4 P31391 1/20 0.39
SSTR3 P32745 1/20 0.39
SSTR5 P35346 1/20 0.39
TNF P01375 1/20 0.39
CES2 O00748 1/20 0.37
GBA1 P04062 1/20 0.37
FGF1 P05230 3/20 0.37
FGF2 P09038 3/20 0.37
VEGFA P15692 3/20 0.37
HPSE Q9Y251 3/20 0.37
CA2 P00918 1/20 0.37
CYP2D6 P10635 1/20 0.36
THRB P10828 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10895352 1.00 BCHE (0.43) BCHEGJB2MAPK1SSTR1SSTR2
SCHEMBL5986141 1.00 BCHE (0.43) BCHEGJB2MAPK1SSTR1SSTR2
SCHEMBL9802903 1.00 BCHE (0.43) BCHEGJB2MAPK1SSTR1SSTR2
SCHEMBL3344752 1.00 BCHE (0.43) BCHEGJB2MAPK1SSTR1SSTR2
SCHEMBL15837031 0.95 GJB2 (0.42) BCHEGJB2MAPK1SSTR1SSTR2
SCHEMBL16404499 0.95 GJB2 (0.42) BCHEGJB2MAPK1SSTR1SSTR2
SCHEMBL12942195 0.91 BCHE (0.45) BCHEGJB2MAPK1SSTR1SSTR2
SCHEMBL7041125 0.88 BCHE (0.46) BCHEGJB2MAPK1CES2CA2
SCHEMBL7041122 0.88 BCHE (0.46) BCHEGJB2MAPK1CES2CA2
SCHEMBL15369122 0.87 GJB2 (0.41) BCHEGJB2MAPK1SSTR1SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394935-B2 Method for producing furanose derivative API CORPORATION (JP) 2013-03-12 US disclosed
US-20100105890-A1 METHOD FOR PRODUCING FURANOSE DERIVATIVE API CORPORATION (JP) 2010-04-29 US disclosed
EP-2105445-A1 METHOD FOR PRODUCTION OF FURANOSE DERIVATIVE API Corporation (JP) 2009-09-30 EP disclosed
EP-1634888-A2 Synthesis of 2'-deoxy-L-nucleosides Pharmasset Limited (US) 2006-03-15 EP disclosed
EP-1600451-A2 Synthesis of 2'-deoxy-l-nucleosides Pharmasset Limited (US) 2005-11-30 EP disclosed
EP-1600452-A2 Synthesis of 2'-deoxy-L-nucleosides Pharmasset Limited (US) 2005-11-30 EP disclosed
US-20050090660-A1 2'-deoxy-L-nucleosides PHARMASSET, INC. 2005-04-28 US disclosed
US-4614719-A REACTION OF 1,2,4-TRIAZOLE-CARBOXAMIDE AND RIBOSE DONOR IN PRESENCE OF BREVEBACTERIUM CATALYST YAMASA SHOYU KABUSHIKI KAISHA (JP) 1986-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090660-A1 2'-deoxy-L-nucleosides CCNH, ADAR, NSUN2 BCHE 1221/4885GJB2 3377/4885MAPK1 4173/4885
US-20100105890-A1 METHOD FOR PRODUCING FURANOSE DERIVATIVE DERA, ALDOA, DPYD BCHE 1903/4885GJB2 4735/4885MAPK1 4584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.